病人之后接受一年的抗结核药治疗。
The patient was put on a 1-year treatment regimen of anti-tuberculosis medication.
比较环丙沙星或氧氟沙星联用抗结核药的肝毒性。
To compare hepatic toxic injury induced by concomitant use of ciproxacin or ofloxacin and isoniazid and rifampicin in mice.
目的：研究氧氟沙星联用抗结核药的肝毒性并探讨其机制。
Objective: to study hepatic toxic injury induced by ofloxacin with Antituberculosis drugs in mice.
目的了解抗结核药致肝损害危险因素，为结核病合理化疗提供依据。
Objective to understand risk factors of hepatic toxicity of antituberculosis agents and provide scientific basis for tuberculosis chemotherapy.
经抗生素、非甾体抗炎药、抗结核药、皮质类固醇激素等治疗可使病情缓解或痊愈。
The patients' condition was to be getten remission with the therapy of antibiotics, non-Steroid anti-inflammatory drugs, anti-tubercle drugs and corticosteroids.
耐多药结核描述至少对两种主要一线抗结核药物-异烟肼和利福平具耐药性的结核菌株。
MDR-TB (Multidrug Resistant TB) describes strains of tuberculosis that are resistant to at least the two main first-line TB drugs - isoniazid and rifampicin.
西药占48.6%（53/109），居前三位的依次为解热镇痛消炎药、抗结核药、抗甲状腺药。
The western medicine accounted for 48.6%(53/109), among which the most chief drugs were anti-inflammatory, antipyretic, antituberculotic and antithyroid drugs.
目的：了解当前结核病对一线及二线抗结核药物的耐药性及耐多药情况，为结核病防治提供依据。
Objective: To investigate the resistance status of Bacillus tuberculosis to anti?tuberculosis drugs of fist and second ranks in use, and so as to provide basic data for tuberculosis (TB)prevention .
结论：将抗结核药利福平制备成微球制剂，肺部分可提高药物在肺部的分布，静注后无明显不良反应。
CONCLUSION: the lung tissue pulmonary distribution rate of rifampin may be promoted by making rifampin into microsphere dosage form and there were no significant side effects.
结论：与单纯采用抗结核药进行治疗相比，乌体林斯联合抗结核药治疗肺结核球效果好，不良反应少。
Conclusion: Only using the anti-TB drug treatment compared with Utilin's combined with anti-TB drugs treatment of pulmonary tuberculosis, the latter is good effect, and less adverse reaction.
结论既往肝炎病史、糖尿病史、乙肝病毒标志物阳性、年龄60岁以上、酒精依赖等是抗结核药致肝损害危险因素。
Conclusion Hepatitis history, diabetic, HBV positive marker, alcoholic dependence or age above 60 years is risk factors of hepatic toxicity of antituberculosis agents.
方法：采用含卷曲霉素、结核清、氧氟沙星、复合利福平及吡嗪酰胺等抗结核药物方案对耐多药肺结核患者进行治疗。
Methods: The tuberculosis of multi-drug resistance were treated with capreomycin, pasinizide, ofloxacin, rifampin compound and pyrazinamide for one year.
耐多药结核病是耐药结核病的一种特殊形式，由于某一杆菌至少对异烟肼和利福平这两个最强有力的抗结核药品产生耐药而造成。
MDR-TB is a specific form of drug-resistant TB due to a bacillus resistant to at least isoniazid and rifampicin, the two most powerful anti-TB drugs.
在一定程度上，由于它的支持，27种有潜力的抗结核药正从不同的岔道通过生产线，即从可能的分子转变为医生可以开出的药品。
Partly under its aegis, 27 potential anti-TB drugs are at various points along the pipeline that leads from a promising molecule to a medicine that doctors can prescribe.
去年世卫组织抗结核耐药报告说明了在一般人群中结核病耐多药情况已达到前所未有的最高水平。
Last year, the WHO report on anti-TB drug resistance documented the highest levels of multi-drug resistance ever recorded in a general population.
耐多药结核病是由对多数有效抗结核病药物（异烟肼和利福平）都具有耐药性的细菌引起的。
MDR-TB is caused by bacteria that are resistant to the most effective anti-TB drugs (isoniazid and rifampicin).
目的：建立含药血清作用结核杆菌感染巨噬细胞模型的抗结核杆菌药物活性检测方法，探讨该方法在评价抗结核杆菌药物活性中的应用。
Objective: To find a method of evaluating anti-Mycobacterium tuberculosis (TB) medicine using medicine containing serum and infected macrophage model and investigate its practicability and merits.
掌握异烟肼、利福平作用机制、临床应用、主要不良反应。 熟悉其它抗结核病药及抗麻风病药的临床选药。
Chapter 45 Antituberculous drugs and Antileprosy drugs Master the mechanisms of action, therapeutic applications and major adverse reactions of isoniazid and rifampin.
掌握异烟肼、利福平作用机制、临床应用、主要不良反应。 熟悉其它抗结核病药及抗麻风病药的临床选药。
Chapter 45 Antituberculous drugs and Antileprosy drugs Master the mechanisms of action, therapeutic applications and major adverse reactions of isoniazid and rifampin.
应用推荐